HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −68−100.0% | Sold out | Holders |
| Q4 2025 | 68 | $27.0K | <0.1% | +68 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −252−100.0% | Sold out | Holders |
| Q4 2024 | 252 | $59.3K | <0.1% | +252 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −218−100.0% | Sold out | Holders |
| Q4 2021 | 218 | $37.0K | <0.1% | +218 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −465−100.0% | Sold out | Holders |
| Q1 2021 | 465 | $66.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.